actrapid hm 100iu/ml penfill - Human insulin (100IU) medicine

Actrapid HM 100IU/ml Penfill: Complete Medicine Guide

No reviews yet
🏭 Novo Nordisk India Pvt Ltd 📦 Varies by brand 💊 Allopathy 📅 Updated: Oct 16, 2026
📋 Prescription Required 💊 Generic Available
Medically Reviewed
11 min read
Evidence: Well-established for acute glycemic control in hospital settings.
Reviewed by
SaathiMed Expert Panel | Oct 16, 2026
🩺
Medically Fact-Checked & Clinically Verified by SaathiMed Clinical Review Board
Clinical Reference Standards: CDSCO (Central Drugs Standard Control Organisation), Indian Pharmacopoeia (IP) & WHO | Last Updated: September 2026

When to Call Your Doctor IMMEDIATELY

  • Severe hypoglycemia with confusion, seizures, or unconsciousness
  • Signs of anaphylaxis such as rash, swelling, or difficulty breathing
  • Severe hypokalemia with muscle weakness or cardiac arrhythmias
  • Persistent hyperglycemia despite increasing insulin infusion
  • Infusion site redness, swelling, or pus
  • Sudden decrease in urine output or swelling in legs

If experiencing severe symptoms, call emergency services immediately.

What is actrapid hm 100iu/ml penfill used for?

This medicine is a rapid-acting human insulin given intravenously in hospitals to quickly lower blood glucose in emergencies like diabetic ketoacidosis and during surgery. It must only be administered by healthcare professionals with close monitoring.

  • Generic Name: Human insulin
  • Manufacturer: Novo Nordisk India Pvt Ltd
  • Form: Allopathy
  • Pregnancy Category: Consult doctor
  • Prescription Required: Yes

🇮🇳 actrapid hm 100iu/ml penfill के बारे में (Hindi Summary)

उपयोग: यह दवा मानव इंसुलिन का एक तेज़ असर वाला रूप है, जिसे अस्पताल में नस के माध्यम से दिया जाता है। इसका उपयोग मधुमेह के गंभीर मामलों जैसे डायबिटिक कीटोएसिडोसिस, अत्यधिक उच्च रक्त शर्करा, और सर्जरी के दौरान रक्त शर्करा को नियंत्रित करने के लिए किया जाता है। यह दवा केवल डॉक्टर या प्रशिक्षित स्वास्थ्य कर्मचारी द्वारा ही दी जानी चाहिए।

साइड इफेक्ट्स: इस दवा के सामान्य दुष्प्रभावों में रक्त शर्करा का कम होना (हाइपोग्लाइसीमिया), पसीना आना, कंपकंपी, और घबराहट शामिल हैं। गंभीर दुष्प्रभावों में बेहोशी, दौरे, और एलर्जी प्रतिक्रियाएँ हो सकती हैं। यदि आपको कोई असामान्य लक्षण दिखे तो तुरंत डॉक्टर को बताएं।

सुरक्षा सलाह: यह दवा केवल अस्पताल में डॉक्टर की देखरेख में ही दी जाती है। इसे कभी भी घर पर स्वयं न लगाएं। रक्त शर्करा और पोटैशियम की नियमित जांच आवश्यक है। अपने डॉक्टर को सभी दवाओं के बारे में बताएं। यदि रक्त शर्करा कम होने के लक्षण दिखें तो तुरंत इलाज कराएं।

💡 Did You Know? India has the highest number of USFDA-compliant plants outside the USA.

💊 actrapid hm 100iu/ml penfill Uses & Benefits

[{"condition":"Diabetic ketoacidosis","description":"This medicine is used intravenously to rapidly lower blood glucose and suppress ketone production in patients with diabetic ketoacidosis.","evidence":"Well-established"},{"condition":"Hyperglycemic hyperosmolar state","description":"It helps reduce extremely high blood glucose levels in hyperglycemic hyperosmolar state under close monitoring.","evidence":"Well-established"},{"condition":"Perioperative glycemic control","description":"This medicine is used during surgery and recovery to maintain blood glucose within target ranges in patients with diabetes.","evidence":"Well-established"},{"condition":"Critical illness hyperglycemia","description":"It is used in intensive care settings to manage stress-induced hyperglycemia in critically ill patients.","evidence":"Well-established"}]

Off-label uses: [{"condition":"Hyperkalemia","description":"This medicine may be used off-label with glucose to shift potassium into cells in emergency hyperkalemia management.","evidence":"Limited"}]

Primary treatment for: Diabetes mellitus requiring acute intravenous insulin therapy

Also treats: Diabetic ketoacidosis, Hyperglycemic hyperosmolar state, Perioperative hyperglycemia, Critical illness hyperglycemia

📋 Drug Information

Generic Name(s)Human insulin
Brand NameActrapid HM 100IU/ml Penfill
ManufacturerNovo Nordisk India Pvt Ltd
Packaging / FormVaries by brand (Allopathy)
Therapeutic ClassANTI DIABETIC
Action ClassHuman insulin- short acting
Route of AdministrationIntravenous (IV) infusion or injection, administered by a qualified healthcare professional
StorageStore unopened penfill cartridges in a refrigerator between 2°C and 8°C. Do not freeze. Once in use, follow the specific storage instructions provided by your healthcare team. Keep away from direct heat and sunlight.
Shelf LifeRefer to the packaging for the exact shelf life. Typically 24 months from the date of manufacture when stored properly.
WHO GuidelineNot established from the available information.
ICMR GuidelineNot established from the available information.

👨‍⚕️ Doctor's Practical Tips

Evidence-based practical advice from experienced clinicians

1
Always verify the insulin concentration and expiration date before administration.
2
Monitor blood glucose every 30-60 minutes during intravenous infusion.
3
Check potassium levels regularly, as insulin can cause hypokalemia.
4
Adjust infusion rate based on hourly glucose readings and clinical response.
5
Ensure sterile technique to prevent infection at the infusion site.
6
Educate patients and caregivers about recognizing hypoglycemia symptoms.

🔍 Is This Medicine Right for Your Symptom?

Educational reference. Always consult a doctor for diagnosis.

✅
High blood sugar (hyperglycemia)
This medicine is used to rapidly lower blood glucose in acute settings.
Likely Use
✅
Ketones in urine
This medicine helps clear ketones in diabetic ketoacidosis.
Likely Use
❌
Fever
This medicine is not used to treat fever.
Not Primary

🔬 How This Medicine Works (Pharmacology)

Pharmacokinetics

AbsorptionThis medicine is administered intravenously, so absorption is not applicable. It enters the bloodstream directly and is immediately available.
DistributionAfter intravenous administration, this medicine distributes rapidly into extracellular fluids and tissues. Its volume of distribution is approximately 0.1 to 0.2 L/kg. It does not cross the placenta in significant amounts, but it is present in breast milk in small quantities.
Protein BindingHuman insulin is minimally bound to plasma proteins, with less than 5% binding reported.
MetabolismThis medicine is metabolized primarily in the liver, kidneys, and muscle tissue by insulin-degrading enzyme and glutathione-insulin transhydrogenase. It is broken down into amino acids and small peptides.
Half-LifeThe elimination half-life of intravenously administered human insulin is approximately 5 to 10 minutes.
ExcretionMetabolites of this medicine are excreted primarily in the urine and to a lesser extent in bile.
BioavailabilityBioavailability is 100% when administered intravenously.
Onset of ActionOnset of action is immediate, within 10 to 20 minutes after intravenous administration.
Peak Plasma TimePeak plasma concentration occurs within 30 to 60 minutes after intravenous infusion.
Duration of ActionThe duration of action is approximately 1 to 2 hours after intravenous administration.

How It Works

This medicine works by binding to the insulin receptor, a transmembrane tyrosine kinase receptor found on the surface of muscle, fat, and liver cells. Once bound, it triggers autophosphorylation of the receptor and activates intracellular signaling pathways. This leads to translocation of glucose transporter type 4 (GLUT4) to the cell membrane, increasing glucose uptake into muscle and fat cells. In the liver, it promotes glycogen synthesis and inhibits gluconeogenesis and glycogenolysis. It also inhibits lipolysis in adipose tissue and promotes protein synthesis. The overall effect is a rapid reduction in blood glucose levels.

Mechanism Steps

1
Insulin receptor binding: This medicine binds to the alpha subunits of the insulin receptor on the cell membrane.
2
Receptor autophosphorylation: Binding triggers autophosphorylation of the beta subunits, activating the receptor's tyrosine kinase activity.
3
Intracellular signaling: Activated receptor phosphorylates insulin receptor substrates, leading to activation of PI3K and Akt pathways.
4
GLUT4 translocation: Signaling causes GLUT4 vesicles to move to the cell membrane, increasing glucose uptake into muscle and fat cells.
5
Hepatic effects: In the liver, this medicine promotes glycogen storage and inhibits glucose production.
6
Metabolic regulation: It also inhibits lipolysis and stimulates protein synthesis, contributing to overall metabolic control.

💡 How to Take actrapid hm 100iu/ml penfill

Strength: 100 IU/mL solution for injection in a penfill cartridge.

1This medicine is administered only by a healthcare professional.
2It is given intravenously, either as a bolus or continuous infusion.
3Blood glucose and potassium levels are monitored before, during, and after administration.
4The dose is adjusted based on your response and clinical condition.
5Never attempt to self-administer this medicine.

Dosage Information

Adult DosageThe dose of this medicine is highly individualized and must be determined by a qualified clinician based on the patient's blood glucose levels, indication, weight, renal and hepatic function, and response to therapy. For diabetic ketoacidosis, an initial intravenous bolus may be followed by a continuous infusion, with doses adjusted according to hourly glucose monitoring. For perioperative control, dosing is titrated to target glucose ranges. Never self-administer this medicine; it is given only under medical supervision.
Pediatric DosagePediatric dosing is not established from available information. Consult a pediatric endocrinologist for individualized dosing.
Elderly DosageElderly patients may be more sensitive to the effects of insulin and are at higher risk of hypoglycemia. Doses should be individualized by a clinician with close monitoring of blood glucose and renal function.
Renal ImpairmentRenal impairment can reduce insulin clearance and increase the risk of hypoglycemia. Dose reduction may be necessary, and close monitoring is required. Consult a clinician for individualized dosing.
Hepatic ImpairmentHepatic impairment can affect insulin metabolism and glucose regulation. Doses should be individualized by a clinician with careful monitoring.
Maximum Daily DoseNot established from the available information. Dosing is individualized based on clinical response and blood glucose monitoring.

Dosage Timeline

🌅 Morning ❌ ☀️ Afternoon ❌ 🌆 Evening ❌ 🌙 Night ❌

🍽️ Food Timing Guide

Any food
No direct food interaction
This medicine is given intravenously; food intake affects blood glucose and insulin needs.

⏰ What to Do If You Miss a Dose

📌 Missed a scheduled hospital dose
→ Inform the nursing staff immediately.
💡 They will assess your blood glucose and decide whether to administer the dose.
📌 Missed a home dose (if prescribed for pen use)
→ Take the missed dose as soon as you remember, but if it is almost time for the next dose, skip the missed dose.
💡 Do not double dose. Consult your doctor for guidance.

⚠️ Side Effects of actrapid hm 100iu/ml penfill

✅ Common Side Effects

Hypoglycemia (Common (10-30%))
Monitor blood glucose closely. If symptoms occur, treat with oral glucose or intravenous dextrose as directed by your healthcare provider.
Hypokalemia (Common (5-15%))
Your doctor will monitor potassium levels and may supplement if needed.
Injection site reactions (Uncommon (1-5%))
Rotate infusion sites and report persistent redness or swelling.

🚨 Serious Side Effects

Severe hypoglycemia (Uncommon (1-5%))
Seek immediate medical attention if you experience confusion, seizures, or loss of consciousness.
Anaphylaxis (Rare (<0.1%))
Discontinue immediately and seek emergency care if you develop rash, swelling, or difficulty breathing.
Severe hypokalemia (Rare (<0.1%))
Requires immediate medical intervention and potassium replacement.

⚠️ Rare Side Effects

Insulin resistance
Consult your doctor; dose adjustment may be needed.
Edema
Usually resolves with continued use; inform your doctor if persistent.

Consult your doctor if you experience any unusual symptoms.

🔬 Drug Interactions

Drug Severity Effect
Beta-blockers Major
Corticosteroids Major
Thiazide diuretics Major
ACE inhibitors Moderate
Alcohol Moderate
Thyroid hormones Minor

🚨 Major Interactions

  • Beta-blockers
  • Corticosteroids
  • Thiazide diuretics

⚡ Moderate Interactions

  • ACE inhibitors
  • Alcohol

🍷 Alcohol Interaction

Alcohol can cause unpredictable changes in blood glucose and increase the risk of severe hypoglycemia. Patients receiving this medicine should avoid alcohol or discuss safe limits with their doctor.

🔎 Check Your Other Medicines

Educational tool. Always confirm with your doctor or pharmacist.

🛡️ Safety & Warnings

🚫 Contraindications

["Hypoglycemia","Hypersensitivity to human insulin or any excipient","Not for self-administration outside a clinical setting"]

⚠️ Warnings & Precautions

["Only for intravenous use under medical supervision.","Monitor blood glucose and potassium closely during infusion.","Adjust dose in renal or hepatic impairment.","May cause severe hypoglycemia; always have glucose available.","Do not use if solution is cloudy or contains particles.","Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding."]

🤱 Lactation Safety

Human insulin is present in breast milk in small amounts but is not expected to harm a nursing infant. Insulin requirements may change during lactation, so monitoring is advised.

💊 Overdose Management

Overdose of this medicine can cause severe hypoglycemia, which may lead to seizures, coma, or death. Immediate treatment with intravenous glucose or glucagon is required. Continuous monitoring of blood glucose and potassium is essential until the patient is stable. In case of accidental overdose, seek emergency medical help immediately.

⏰ Missed Dose

This medicine is administered by healthcare professionals in a controlled setting. Missed doses are not applicable for home use. If a scheduled hospital dose is missed, inform the nursing staff immediately; they will determine whether to administer it based on your current blood glucose and clinical status.

Additional Safety Advice

General Safety

This medicine must only be administered by a qualified healthcare professional in a setting where blood glucose and potassium levels can be monitored closely. Never attempt to self-administer this medicine intravenously. Always check the cartridge for clarity and particles before use; discard if cloudy or discolored. Keep glucose sources available in case of hypoglycemia. Inform your doctor about all other medicines, especially beta-blockers, corticosteroids, and diuretics, as they can affect insulin requirements. Do not share pen devices or cartridges. Store unopened cartridges in a refrigerator and never freeze them. Once in use, follow the specific storage instructions provided by your healthcare team. If you experience symptoms of low blood sugar, seek immediate help.

👴 Special Considerations for Elderly

💡 For Patients Above 65

Elderly patients are at higher risk of hypoglycemia and may have reduced renal function. Doses should be carefully individualized, and blood glucose should be monitored frequently.

🤰 Pregnancy Planning (TTC)

If you are planning pregnancy, discuss your diabetes management with your doctor. Good glycemic control before conception is important. This medicine may be used during pregnancy under medical supervision.

🏥 Post-Surgery Considerations

After surgery, blood glucose levels may fluctuate. This medicine may be continued or transitioned to subcutaneous insulin based on your condition. Close monitoring is required.

🦷 Dental Procedures

Inform your dentist if you are receiving this medicine. Dental procedures may affect your ability to eat, which can impact blood glucose. Your doctor may adjust your insulin dose accordingly.

💚 Lifestyle Tips for Better Results

🏃
Follow your diabetes meal plan as advised by your dietitian.
🥗
Monitor your blood sugar regularly if you have diabetes.
😴
Stay physically active as permitted by your doctor.
💧
Avoid alcohol, as it can cause dangerous blood sugar swings.
🧘
Keep a record of your blood sugar readings and medicines.
🌞
Attend all follow-up appointments for dose adjustments.

🏋️ Exercise Considerations

While receiving this medicine, exercise should be supervised by healthcare providers. Physical activity can affect blood glucose levels and may require dose adjustments. Avoid strenuous exercise without medical clearance.

🥗 Diet Recommendations

Eat regular, balanced meals if allowed.
Include complex carbohydrates and fiber.
Limit sugary drinks and refined carbohydrates.
Stay hydrated with water unless fluid restriction is advised.
Follow any specific dietary instructions from your healthcare team.

💼 Impact on Daily Work & Life

This medicine is used in hospital settings, so it does not directly impact daily work life. After discharge, patients may need to adjust to a new insulin regimen. Driving and operating machinery should be avoided if you experience hypoglycemia. Discuss with your doctor when it is safe to resume normal activities.

🛑 When to Stop This Medicine

This medicine is stopped by healthcare professionals when your blood glucose is stable and you can transition to subcutaneous insulin or oral medications. Never stop or change the dose without medical advice.

📅 Long-Term Use Effects

Long-term use of this medicine is not typical, as it is intended for acute hospital care. Prolonged intravenous insulin therapy may increase the risk of hypoglycemia and hypokalemia. Patients requiring long-term insulin will be transitioned to subcutaneous regimens. Regular monitoring of blood glucose, potassium, and renal function is essential during therapy.

🌿 Non-Medicine Approaches

These can complement medicine but do not replace prescribed treatment.

Subcutaneous insulin

Used for long-term diabetes management after acute stabilization.

Evidence: Well-established
Insulin pump therapy

Continuous subcutaneous insulin infusion for selected patients.

Evidence: Well-established

💉 Vaccination Considerations

💉 If You're Getting Vaccinated

No specific vaccine interactions are established. However, acute illness and vaccination may affect blood glucose control. Consult your doctor about timing of vaccinations.

📦 Storage Guide

✅ DO

Store unopened cartridges in refrigerator (2°C to 8°C)

❌ DON'T

Do not freeze

✅ DO

Keep in original packaging

❌ DON'T

Do not expose to direct sunlight

✅ DO

Follow healthcare team's instructions for in-use storage

❌ DON'T

Do not use if solution is cloudy or discolored

✈️ Traveling with This Medicine

This medicine is typically used in hospital settings and is not for self-administration during travel. If you are prescribed this medicine for use with a pen device in special circumstances, carry it in its original packaging with a prescription copy. Store it in a cool place, avoiding direct sunlight. For air travel, keep it in carry-on luggage and inform security staff. Check customs regulations for carrying insulin. Always carry a doctor&#039;s letter explaining your medical need.

💰 Cost Analysis & Savings

👥 Real Patient Stories

Educational, anonymized scenarios. Individual results may vary.

👤 A 52-year-old man with type 1 diabetes admitted with diabetic ketoacidosis
He received this medicine intravenously in the hospital. His blood glucose was monitored hourly, and the infusion rate was adjusted. Within 24 hours, his glucose levels stabilized, and ketones cleared. He was later transitioned to subcutaneous insulin.
💡 Lesson: Intravenous insulin is life-saving in diabetic ketoacidosis but requires close monitoring and gradual transition to subcutaneous insulin.
👤 A 68-year-old woman undergoing major surgery with poorly controlled diabetes
She was started on this medicine intravenously during surgery to maintain blood glucose within target range. The infusion was titrated based on frequent glucose checks. She experienced no hypoglycemic episodes and recovered well.
💡 Lesson: Perioperative intravenous insulin helps prevent hyperglycemia-related complications and improves surgical outcomes.

💬 Questions Patients Often Ask

Q: How long does it take to work?

A: This medicine starts working within 10 to 20 minutes after intravenous administration, with peak effect in 30 to 60 minutes.

Q: Can I take this medicine at home?

A: No, this medicine is for intravenous use only and must be given by a healthcare professional in a hospital or clinic setting.

Q: What should I do if I feel shaky or sweaty?

A: These are signs of low blood sugar. Inform your nurse or doctor immediately so they can check your glucose and treat you appropriately.

🤔 Common Patient Concerns

💭 These are the concerns patients most commonly raise

  • Can this medicine be used at home?
  • How often will my blood sugar be checked?
  • What are the signs of low blood sugar?
  • Will this medicine affect my potassium levels?
  • Can I eat normally while on this medicine?
  • How long will I need this medicine?

🔄 Substitutes for actrapid hm 100iu/ml penfill

View All

Alternative brands with exact same active ingredient:

Medical Note: Always consult your doctor before switching medications.

🛑 Myths vs. Facts

  • Myth: This medicine can be self-administered like other insulins.
    Fact: This medicine is for intravenous use only and must be given by a healthcare professional in a monitored setting.
  • Myth: This medicine is a long-acting insulin.
    Fact: This medicine is a short-acting insulin with a rapid onset and short duration of action.

🔄 Alternative Options

Generic Alternatives

  • Human insulin 100 IU/mL solution for injection

Brand Alternatives

  • Actrapid HM 100IU/ml Penfill

📊 Comparison with Similar Medicines

[{"medicine":"This medicine","onset":"10-20 minutes","peak":"30-60 minutes","duration":"1-2 hours","route":"Intravenous"},{"medicine":"Insulin lispro","onset":"5-15 minutes","peak":"30-90 minutes","duration":"3-5 hours","route":"Subcutaneous"},{"medicine":"Insulin aspart","onset":"10-20 minutes","peak":"40-50 minutes","duration":"3-5 hours","route":"Subcutaneous"}]

😊 Was this information helpful?

Browse Medicines A-Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Back to Medicines Directory